Maverick Investing

Enrollment of 150 patients in phase 2b/3 trial of RLF-100™
Nov14

Enrollment of 150 patients in phase 2b/3 trial of RLF-100™

NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure – Observations of rapid recovery noted on chest x-ray and no drug-related Serious Adverse Events reported NEWS PROVIDED BY NeuroRx  Nov 13, 2020, 05:00 ET RADNOR, Pa. and GENEVA, Nov. 13, 2020 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF,OTCBB:RLFTF)...

Read More
SolarWindow May Be the Next Generation of Solar
Nov05

SolarWindow May Be the Next Generation of Solar

SolarWindow May Be the Next Generation of Solar A liquid coating that produces electricity and a new executive team are behind WNDW stock By Dana Blankenhorn, InvestorPlace Contributor Oct 15, 2020, 11:07 am EST During the last decade solar power has been produced by expensive, dedicated solar panels, placed on roofs or in fields, and sold as a capital good. During the coming decade solar power will evolve into a consumer product,...

Read More
NeuroRx, Inc. and Relief Therapeutics Holdings AG to continue as planned
Nov05

NeuroRx, Inc. and Relief Therapeutics Holdings AG to continue as planned

RADNOR, Pa. and GENEVA, Nov. 5, 2020 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF, OTCBB:RLFTF) (“Relief”) announced that the independent Data Monitoring Committee (DMC) met yesterday and voted unanimously that NCT 04311697 should continue as planned to its full enrollment of 165 patients. Specifically, the committee identified no safety concerns and viewed the study as capable of...

Read More
RLF-100™ (Aviptadil) Relief Therapeutics Holding AG (OTCMKTS: RLFTF) Heats Up Fast
Oct29

RLF-100™ (Aviptadil) Relief Therapeutics Holding AG (OTCMKTS: RLFTF) Heats Up Fast

RLF-100™ (Aviptadil) Relief Therapeutics Holding AG (OTCMKTS: RLFTF) Heats Up Fast BY PAUL KNAG ON OCTOBER 26, 2020 Relief Therapeutics Holding AG (OTCMKTS: RLFTF) is surging up the charts in recent trading since a recent test of the bottom of its current trading range. Relief Therapeutics is quickly emerging as among the most exciting stories in small caps as its coronavirus therapeutic RLF-100 (aviptadil) gains serious traction. The...

Read More
First Mover: Bitcoin Steady Over $13K as JPMorgan Has Eureka! Moment
Oct29

First Mover: Bitcoin Steady Over $13K as JPMorgan Has Eureka! Moment

First Mover: Bitcoin Steady Over $13K as JPMorgan Has Eureka! Moment Bitcoin was higher, appearing to hold above $13,000 for the first time since January 2018. But the most drama in crypto markets came after an exploit of the decentralized finance protocol Harvest Finance sent the platform’s native FARM token tumbling by 65% in less than an hour. In traditional markets, European stocks slid as Spain declared a COVID-19 state of...

Read More
Billionaire Paul Tudor Jones Sees Massive Upside in Bitcoin, Like Investing in Apple or Google Early
Oct26

Billionaire Paul Tudor Jones Sees Massive Upside in Bitcoin, Like Investing in Apple or Google Early

Billionaire Paul Tudor Jones Sees Massive Upside in Bitcoin, Like Investing in Apple or Google Early NEWS by Kevin Helms American billionaire hedge fund manager Paul Tudor Jones has recently become more bullish on bitcoin. He declared the cryptocurrency the best hedge against inflation and compares investing in bitcoin now to investing in early tech stocks, like Apple and Google. “I think we are in the first inning of bitcoin and it’s...

Read More
Price analysis 10/21: BTC, ETH, XRP, BCH, BNB, LINK, DOT, LTC, ADA, BSV
Oct26

Price analysis 10/21: BTC, ETH, XRP, BCH, BNB, LINK, DOT, LTC, ADA, BSV

Price analysis 10/21: BTC, ETH, XRP, BCH, BNB, LINK, DOT, LTC, ADA, BSV RAKESH UPADHYAY Bitcoin hit a new 2020 high and altcoins rallied as PayPal announced that it will support crypto payments. The crypto markets are cheering PayPal’s decision to allow its customers to use cryptocurrencies to shop from its vast merchant network. PayPal also revealed that U.S. account holders will be able to buy, sell, and hold cryptocurrencies in the...

Read More
Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
Oct22

Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout

Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout   Relief and NeuroRx are still awaiting the detailed results from rigorous randomised studies of RLF-100 (aviptadil) for the treatment of COVID-19 patients. However, in top-line results from an open-label prospective study of patients who had severe comorbidities that meant they were ineligible for the ongoing controlled phase 2/3b trial, RLF-100...

Read More
A Former Goldman Sachs Hedge Fund Chief Has Predicted Bitcoin Will Surge To $1 Million—Here’s Why
Oct19

A Former Goldman Sachs Hedge Fund Chief Has Predicted Bitcoin Will Surge To $1 Million—Here’s Why

Billy BambroughContributor Crypto & Blockchain I write about how bitcoin, crypto and blockchain can change the world. The bitcoin price has added some 40% over the last 12 months. COINBASE A Former Goldman Sachs Hedge Fund Chief Has Predicted Bitcoin Will Surge To $1 Million—Here’s Why Bitcoin has found fresh support this year, bolstered by growing disquiet among investors over central bank and government stimulus measures. The...

Read More
Our Largest SolarWindow
Aug28

Our Largest SolarWindow

SolarWindow Technologies, Inc. (Symbol: WNDW) today released scheduled video footage of its largest ultra-transparent SolarWindow™, discretely generating electricity to power lighting and drive a digital multimeter. Capable of generating current and voltage while maintaining the transparent nature of ordinary glass, the featured nine-square-foot SolarWindow™ was created using the Company’s patented LiquidElectricity™ coatings. See the...

Read More
Under $1 Surging Stock To Consider: Relief Therapeutics Holding AG
Aug21

Under $1 Surging Stock To Consider: Relief Therapeutics Holding AG

Relief Therapeutics (OTC: RLFTF) is one of the steeply rising stocks since the beginning of August. From $0.0395 to $0.5435 RLFTF has rocketed just during August on the average volume of 14,307,361 shares. For developing RLF-100, an inexpensive drug against COVID-19 the shares are keen to surge further. In progress, clinical trials are yet to come on the way to challenge the drug RLF-100. If any success comes out RLFTF will skyrocket...

Read More
New Video: Look Through Our Most Transparent Electricity-Generating SolarWindow™, Ever
Jul31

New Video: Look Through Our Most Transparent Electricity-Generating SolarWindow™, Ever

VESTAL, N.Y., July 22, 2020 (GLOBE NEWSWIRE) — SolarWindow Technologies, Inc. (Symbol: WNDW) today released first-person video footage demonstrating its new, highly transparent electricity-generating glass to its stakeholders, building owners, developers, and architects. Click here to see first-hand, your own clear view through our most transparent electricity-generating SolarWindow™. SolarWindow™ transparent...

Read More
US Stock Market Enters Parabolic Price Move – Be Prepared, Part II
Jun30

US Stock Market Enters Parabolic Price Move – Be Prepared, Part II

In the first part of this research article, we briefly discussed the recent price and global economic events related to the 2018 to 2020 US stock market volatility and the COVID-19 virus event.  The premise of this research post was to highlight the current upside parabolic price trend that initiated shortly after the 2015~16 US election cycle event.  It is almost impossible to look at the NAS100 chart, below, and not see the dramatic...

Read More
A broken uptrend in a key government bond yield could be a bad omen for stocks
Jun29

A broken uptrend in a key government bond yield could be a bad omen for stocks

Yield on benchmark 10-year Treasury and the S&P 500 have been mostly in sync this year, so a breakdown in one suggests the other is likely to follow. So much for the V-shaped recovery. The yield on the benchmark 10-year Treasury note TMUBMUSD10Y, 0.625% just broke below a rising trend line, to suggest the uptrend off the COVID-19 low in early March has ended. That uptrend in rates was significant for both Main Street and Wall...

Read More
US Stock Market Enters Parabolic Price Move – Be Prepared, Part I
Jun25

US Stock Market Enters Parabolic Price Move – Be Prepared, Part I

After the recent COVID-19 virus event and the global market concerns that will warrant caution for skilled traders and investors, the US stock markets have entered an upside parabolic trend that will likely end with a massive price collapse – extremely volatile and aggressive in nature.  Our research team continues to warn of the unpredictable nature of the current price rally and the fact that the upside parabolic price trend appears...

Read More
Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation
Jun16

Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

VANCOUVER, British Columbia , June 12, 2020 /PRNewswire/ — Mydecine Innovations Group Inc. (MYCO.CN) (NLBIF) (0NF.F) (“Mydecine” or the “Company”), is pleased to announce the establishment of a research division agreement with Applied Pharmaceutical Innovation (“API”), a translational commercial drug development institute hosted in the University of Alberta’s Faculty of Pharmacy and...

Read More
NewLeaf Brands To Buy Mushroom Company Mydecine
May21

NewLeaf Brands To Buy Mushroom Company Mydecine

NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) has signed a letter of intent to purchase Colorado-based  Mydecine Group in an all-stock deal valued at $850,000.  Mydecine is a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the many compounds found in various strains of mushroom and fungi as a whole. “We’ve been watching and closely monitoring the progress of the mycology space for...

Read More
Maverick Investing: SURVIVAL is the keynote here!
Apr16

Maverick Investing: SURVIVAL is the keynote here!

What is the keynote of the material plane?  SURVIVAL is our most important mandate.  In the world of investments– in which one calculates risk vs reward, SURVIVAL is key.  This means DON’T LOSE YOUR MONEY!  Of course they say “a fool and his money are soon parted.”  Some others regard investment into the stock market as a foolish form of wild gambling.  If we take a look at the massive gyrations of the ups and...

Read More
It’s Your Money: Get Ready for Tax Day ‘20
Nov01

It’s Your Money: Get Ready for Tax Day ‘20

We hate to say it, but Tax Day 2020 is only five and a half months away. It may seem like an eternity right now, but you may wish to start planning now for deferring income to offset your tax liabilities.

Read More
It’s Your Money: When to Use Trusts
Sep29

It’s Your Money: When to Use Trusts

Trusts are tools you can use to protect your assets or to ensure your heirs receive the inheritance you want them to receive. Learn more from Charles Spence with Maynes Bradford Shipps & Sheftel.

Read More